Copyright Reports & Markets. All rights reserved.

Global Onychomycosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Onychomycosis Treatment Market Overview

    • 1.1 Product Overview and Scope of Onychomycosis Treatment
    • 1.2 Classification of Onychomycosis Treatment by Types
      • 1.2.1 Global Onychomycosis Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Onychomycosis Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Medication
      • 1.2.4 Lasers
      • 1.2.5 Photodynamic Therapy
    • 1.3 Global Onychomycosis Treatment Market by Application
      • 1.3.1 Global Onychomycosis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Dermatology Clinics
      • 1.3.4 Retail Pharmacies
      • 1.3.5 Online Pharmacies
    • 1.4 Global Onychomycosis Treatment Market by Regions
      • 1.4.1 Global Onychomycosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Onychomycosis Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Onychomycosis Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Onychomycosis Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Onychomycosis Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Onychomycosis Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Onychomycosis Treatment (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Business Overview
      • 2.1.2 Onychomycosis Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis
      • 2.2.1 Business Overview
      • 2.2.2 Onychomycosis Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Johnson & Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Onychomycosis Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson & Johnson Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Bausch Health
      • 2.4.1 Business Overview
      • 2.4.2 Onychomycosis Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Bausch Health Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bayer
      • 2.5.1 Business Overview
      • 2.5.2 Onychomycosis Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bayer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Lumenis
      • 2.6.1 Business Overview
      • 2.6.2 Onychomycosis Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Lumenis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Galderma
      • 2.7.1 Business Overview
      • 2.7.2 Onychomycosis Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Galderma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Moberg Pharma
      • 2.8.1 Business Overview
      • 2.8.2 Onychomycosis Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Moberg Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Cipla
      • 2.9.1 Business Overview
      • 2.9.2 Onychomycosis Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Cipla Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Biofrontera
      • 2.10.1 Business Overview
      • 2.10.2 Onychomycosis Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Biofrontera Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Leo Pharma
      • 2.11.1 Business Overview
      • 2.11.2 Onychomycosis Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Leo Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Dr. Reddy's Laboratories
      • 2.12.1 Business Overview
      • 2.12.2 Onychomycosis Treatment Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Medimetriks Pharmaceuticals
      • 2.13.1 Business Overview
      • 2.13.2 Onychomycosis Treatment Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Onychomycosis Treatment Market Competition, by Players

    • 3.1 Global Onychomycosis Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Onychomycosis Treatment Players Market Share
      • 3.2.2 Top 10 Onychomycosis Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Onychomycosis Treatment Market Size by Regions

    • 4.1 Global Onychomycosis Treatment Revenue and Market Share by Regions
    • 4.2 North America Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    5 North America Onychomycosis Treatment Revenue by Countries

    • 5.1 North America Onychomycosis Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Onychomycosis Treatment Revenue by Countries

    • 6.1 Europe Onychomycosis Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Onychomycosis Treatment Revenue by Countries

    • 7.1 Asia-Pacific Onychomycosis Treatment Revenue by Countries (2014-2019)
    • 7.2 China Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    8 South America Onychomycosis Treatment Revenue by Countries

    • 8.1 South America Onychomycosis Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Onychomycosis Treatment by Countries

    • 9.1 Middle East and Africa Onychomycosis Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

    10 Global Onychomycosis Treatment Market Segment by Type

    • 10.1 Global Onychomycosis Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Onychomycosis Treatment Market Forecast by Type (2019-2024)
    • 10.3 Medication Revenue Growth Rate (2014-2024)
    • 10.4 Lasers Revenue Growth Rate (2014-2024)
    • 10.5 Photodynamic Therapy Revenue Growth Rate (2014-2024)

    11 Global Onychomycosis Treatment Market Segment by Application

    • 11.1 Global Onychomycosis Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Onychomycosis Treatment Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Dermatology Clinics Revenue Growth (2014-2019)
    • 11.5 Retail Pharmacies Revenue Growth (2014-2019)
    • 11.6 Online Pharmacies Revenue Growth (2014-2019)

    12 Global Onychomycosis Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Onychomycosis Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Onychomycosis Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Onychomycosis Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Onychomycosis Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Onychomycosis Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Onychomycosis Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Onychomycosis Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Onychomycosis Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Onychomycosis Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Onychomycosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Onychomycosis Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Pfizer
      Novartis
      Johnson & Johnson
      Bausch Health
      Bayer
      Lumenis
      Galderma
      Moberg Pharma
      Cipla
      Biofrontera
      Leo Pharma
      Dr. Reddy's Laboratories
      Medimetriks Pharmaceuticals

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Medication
      Lasers
      Photodynamic Therapy

      Market Segment by Applications, can be divided into
      Hospitals
      Dermatology Clinics
      Retail Pharmacies
      Online Pharmacies

      Buy now